Skip to main content
Vital Chemtech Limited logo

Vital Chemtech Limited — Investor Relations & Filings

Ticker · VITAL ISIN · INE0L4K01016 LEI · 335800ILC78PRID95F06 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2024-09-03 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VITAL

About Vital Chemtech Limited

https://www.vitalgroup.co.in/

Vital Chemtech Limited specializes in the production of phosphorus derivatives and specialty chemicals. The core product range includes Phosphorus Trichloride, Phosphorus Oxychloride, and Phosphorus Pentachloride, which function as essential intermediates for the agrochemical, pharmaceutical, and polymer sectors. The organization operates advanced manufacturing facilities equipped with modern technology to ensure high-purity output and adherence to international quality standards. Its technical capabilities extend to the development of customized chemical solutions and process optimization through dedicated research and development. By focusing on efficient production cycles and technical expertise, the company supports diverse industrial applications requiring precise chemical formulations and reliable supply chain integration.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal announcement addressed to the stock exchange regarding the outcome of a Board Meeting held on September 3, 2024. It details approvals related to the Draft Directors' Report for the financial year 2023-24, scheduling of the 3rd Annual General Meeting (AGM), record date for dividend eligibility, appointment of e-voting agency and scrutinizer, and other procedural matters. The document does not contain the full Annual Report or financial statements but rather informs about decisions made in the Board Meeting and upcoming events related to the AGM and dividend. The document length is 2567 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about board meeting outcomes and AGM scheduling, not the report itself or detailed financial data.
2024-09-03 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the non-applicability of a specific regulation (Regulation 27(2) of SEBI Listing Obligations and Disclosure Requirements) for the company. It states that the company is exempt from filing quarterly/half yearly/yearly Corporate Governance Reports due to its listing on the SME Emerge Platform. The document is a formal notification or regulatory communication rather than a report containing financial data or detailed governance information. It is short (1443 characters) and serves as an announcement or declaration to the exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details of share certificates dematerialized for the quarter ended June 30, 2024. It is addressed to the Listing Compliance Department of the National Stock Exchange and includes a confirmation from the Registrar and Share Transfer Agent. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. The document length is short (2515 characters) and primarily serves as a certification letter. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2024-07-11 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India Limited, providing an update under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the receipt of a Provisional Consent Order from the Gujarat Pollution Control Board for the subsidiary company. The document includes details about the regulatory approval, its validity, and the environmental compliance aspects. There are no financial statements, earnings data, or management discussion of financial results. The document is an announcement of a regulatory approval event relevant to the company, fitting the category of a regulatory announcement under SEBI regulations. It is not a full report, audit, or financial filing but a regulatory update. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (9662 characters) and content confirm it is not a mere report publication announcement but a substantive regulatory update.
2024-06-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to the National Stock Exchange of India Limited, referencing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces that the company, Vital Chemtech Limited, has obtained a Certificate of Registration for a Trademark (No. 5535672) in Class 1. The document includes details about the trademark registration, its validity, and the regulatory authority involved. There are no financial statements, earnings data, or management discussion of financial results. The document is an update or announcement about a regulatory/licensing event rather than a financial report or detailed presentation. It fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like Annual Report, Earnings Release, or Capital Update.
2024-06-12 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India Limited under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements. It announces that the company, Vital Chemtech Limited, has received a license from the Bureau of Indian Standards (BIS) to use a standard mark for a specific product. The document includes details about the license, its validity, and the regulatory context. There are no financial statements, earnings data, or management discussion of financial results. The document is an update on a regulatory approval/license received by the company, which is a compliance-related announcement. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a license approval under SEBI regulations, which aligns with the category Regulatory Filings (RNS). The document length (6574 characters) and content confirm it is not a mere report publication announcement but a substantive regulatory update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-06-12 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.